MiMedx Group Inc (MDXG), Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): A Trio of Horrendous Health-Care Stocks This Week

Page 2 of 2

However, each could also bounce back. I suspect that MiMedx Group Inc (NASDAQ:MDXG) will square away its problems with the FDA. Cytokinetics, Inc. (NASDAQ:CYTK) still has a shot at success with its experimental heart failure drug. And who knows? Maybe VIVUS’ new CEO will help get things going in a positive direction.

Losing a football game doesn’t mean the season is ruined. Likewise, one horrendous week doesn’t mean a stock is necessarily a bad long-term pick.

The article 3 Horrendous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights and The Motley Fool have no position in any of the stocks mentioned. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2